Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. Teva says shareholders favor management as shakeup fizzles

    Headlines

    Wed, 30 Jul 2014

    July 30 (Reuters) - Israeli drugmaker Teva Pharmaceuticals Industries said on Wednesday it turned back efforts by Israeli industrialist Benny Landa to shake up the company's board of directors, with shareholders approving all of the company's proposals and board nominations.

  2. Ebola-stoked money flowing into Tekmira

    Headlines

    Wed, 30 Jul 2014

    Shares of thinly-traded Tekmira Pharmaceuticals ( TKMR +16.6% ) jump on a 3x surge in volume as investors anticipate FDA action to the persistent Ebola outbreak in Africa

  3. Sagent updates guidance after Q2 results

    Headlines

    Wed, 30 Jul 2014

    Sagent Pharmaceuticals ( SGNT +0.7% ) Q2 results : Net Revenue: $69.2M (+16%); Gross Profit: $22.6M (-3%); Operating Expenses

  4. New Morningstar Analyst Report for Vertex Pharmaceuticals Inc

    Stock Reports

    Wed, 30 Jul 2014

    willing to sell material amounts of stock rather than maintain their shareholdings as long-term investors. Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. The firm's lead drug is Kalydeco

  5. Alirocumab successful in nine Phase 3 trials

    Headlines

    Wed, 30 Jul 2014

    Regeneron Pharmaceuticals (NASDAQ: REGN ) and partner Sanofi (NYSE: SNY ) ( OTCQB:SNYNF ) report that their PCSK9 inhibitor alirocumab met its primary

  6. Ligand: Pipeline Breakdown Reveals Bullish Outlook

    Headlines

    Wed, 30 Jul 2014

    indications, drug targets and industry partners. Ligand Pharmaceuticals (NASDAQ: LGND ) is no exception. During a time of ..... drugs which have placed top-line pressure on large pharmaceutical companies , as well as increasing competition in many therapeutic

  7. New Morningstar Analyst Report for Regeneron Pharmaceuticals Inc

    Stock Reports

    Wed, 30 Jul 2014

    and chief scientific officer, George Yancopoulos, received a staggering $81.6 million in 2012. Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cancer and inflammation. The company has

  8. Aegerion set to gap up at the open

    Headlines

    Wed, 30 Jul 2014

    Shares of Aegerion Pharmaceuticals (NASDAQ: AEGR ) are up 15% premarket on fair volume. Yesterday, the company reported Q2 results with softer revenue guidance. Post your comment!

  9. Bayer updates guidance after Q2 results

    Headlines

    Wed, 30 Jul 2014

    BAYRY ) Q2 results: (€M): Group Sales: 10,458 (+0.9%), HealthCare: 4,845 (+0.9%), Pharmaceuticals : 4,845 (+0.9%), Consumer Health: 2,960 (+4.6%), CropScience: 2,470 (+3.3

  10. New Morningstar Analyst Report for Rayonier Advanced Materials Inc

    Stock Reports

    Wed, 30 Jul 2014

    the company's products are used in a variety of applications, including cigarette filters, LCDs, paints, pharmaceuticals , and food. The company spun off from Rayonier, a timber REIT, in June 2014. Increased competition in this highly

« Prev12345Next »
Content Partners